Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04703192 |
|---|---|
| Brief Title: | Valemetostat Tosylate (DS-3201b), an Enhancer of Zeste Homolog (EZH) 1/2 Dual Inhibitor, for Relapsed/Refractory Peripheral T-Cell Lymphoma (VALENTINE-PTCL01) |
| First Submitted : | January 7, 2021 |
| First Submitted that Met QC Criteria : | January 7, 2021 |
| First Posted : | January 11, 2021 |
| Last Update Submitted that Met QC Criteria : | April 11, 2024 |
| Last Update Posted : | April 15, 2024 |